PTC Therapeutics, Inc. announced that on Aug. 17, 2021, it approved non-statutory stock options to purchase an aggregate of 51,670 shares of its common stock and 19,755 restricted stock units, each representing the right to receive one share of its common stock upon vesting, to 48 new employees.
August 20, 2021
· 2 min read